155 related articles for article (PubMed ID: 11354252)
1. Pancreatic and hepatic glycogen content in normoglycemic and hyperglycemic rats.
Malaisse WJ; Ladrière L; Cancelas J; Acitores A; Villanueva-Peñacarrillo ML; Valverde I
Mol Cell Biochem; 2001 Mar; 219(1-2):45-9. PubMed ID: 11354252
[TBL] [Abstract][Full Text] [Related]
2. Labeling of pancreatic glycogen by D-[U-14c]glucose in hyperglycemic rats.
Ladrière L; Louchami K; Laghmich A; Malaisse-Lagae F; Malaisse WJ
Endocrine; 2001 Apr; 14(3):383-97. PubMed ID: 11444437
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic glycogen content in Goto-Kakizaki rats.
Ladriere L; Malaisse WJ
Int J Mol Med; 2001 Feb; 7(2):173-5. PubMed ID: 11172621
[TBL] [Abstract][Full Text] [Related]
4. Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes.
Fierabracci V; De Tata V; Pocai A; Novelli M; Barberà A; Masiello P
Endocrine; 2002 Nov; 19(2):177-84. PubMed ID: 12588048
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin release from the isolated, perfused diabetic rat pancreas: inverse relationship between pancreatic somatostatin and insulin.
Kadowaki S; Taminato T; Chiba T; Goto Y; Nozawa M; Seino Y; Matsukura S; Fujita T
Diabetes; 1980 Dec; 29(12):960-3. PubMed ID: 6108269
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
Hosokawa YA; Hosokawa H; Chen C; Leahy JL
J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of hyperglycemia and associated metabolic abnormalities by a combination of fenugreek (Trigonella foenum-graecum) seeds and onion (Allium cepa) in experimental diabetes.
Pradeep SR; Srinivasan K
J Basic Clin Physiol Pharmacol; 2017 Sep; 28(5):493-505. PubMed ID: 28599386
[TBL] [Abstract][Full Text] [Related]
8. Extract of Woodfordia fruticosa flowers ameliorates hyperglycemia, oxidative stress and improves β-cell function in streptozotocin-nicotinamide induced diabetic rats.
Arya A; Al-Obaidi MM; Karim RB; Taha H; Khan AK; Shahid N; Sayem AS; Looi CY; Mustafa MR; Mohd MA; Ali HM
J Ethnopharmacol; 2015 Dec; 175():229-40. PubMed ID: 26342523
[TBL] [Abstract][Full Text] [Related]
9. Streptozotocin-induced elevation of pancreatic taurine content and suppressive effect of taurine on insulin secretion.
Tokunaga H; Yoneda Y; Kuriyama K
Eur J Pharmacol; 1983 Feb; 87(2-3):237-43. PubMed ID: 6220915
[TBL] [Abstract][Full Text] [Related]
10. Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on hyperglycemia in streptozotocin-induced diabetic rats.
Hirotani Y; Ikeda T; Yamamoto K; Kurokawa N
Biol Pharm Bull; 2007 May; 30(5):1015-20. PubMed ID: 17473455
[TBL] [Abstract][Full Text] [Related]
11. Fate of 2-deoxy-2-[18F]fluoro-D-glucose in control and diabetic rats.
Malaisse WJ; Damhaut P; Malaisse-Lagae F; Ladriere L; Olivares E; Goldman S
Int J Mol Med; 2000 May; 5(5):525-32. PubMed ID: 10762657
[TBL] [Abstract][Full Text] [Related]
12. Glycogen accumulation in rat pancreatic islets: in vitro experiments.
Doherty M; Malaisse WJ
Endocrine; 2001 Apr; 14(3):303-9. PubMed ID: 11444426
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
[TBL] [Abstract][Full Text] [Related]
14. [The effect of oral synthetic protease inhibitor (FOY 305) on endocrine pancreas and carbohydrate and lipid metabolism in normal and streptozotocin-induced diabetic rats].
Eto M; Watanabe K; Kagaya T; Sakai Y; Yoshida S; Oyama K; Futaki G; Saito T; Takebe T; Ishii K
Nihon Naibunpi Gakkai Zasshi; 1984 May; 60(5):684-95. PubMed ID: 6386547
[TBL] [Abstract][Full Text] [Related]
15. Secretin and pancreatic islet blood flow in anesthetized rats: increased insulin secretion with no augmentation of blood perfusion.
Carlsson PO; Jansson L
World J Surg; 2001 Jul; 25(7):835-9. PubMed ID: 11572020
[TBL] [Abstract][Full Text] [Related]
16. Uptake of tritiated glibenclamide by endocrine and exocrine pancreas.
Ladrière L; Malaisse-Lagae F; Malaisse WJ
Endocrine; 2000 Jun; 12(3):329-32. PubMed ID: 10963055
[TBL] [Abstract][Full Text] [Related]
17. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
[TBL] [Abstract][Full Text] [Related]
18. Effects on exocrine and endocrine rat pancreas of long-term administration of CCK-PZ (cholecystokinin-pancreozymin) or synthetic octapeptide - CCK-PZ.
Arnesjö II; Lundquist I
Scand J Gastroenterol; 1976; 11(5):529-35. PubMed ID: 785590
[TBL] [Abstract][Full Text] [Related]
19. Assessment of islet beta-cell mass in isolated rat pancreases perfused with D-[(3)H]mannoheptulose.
Ladrière L; Leclercq-Meyer V; Malaisse WJ
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E298-303. PubMed ID: 11440906
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretion and islet endocrine cell content at onset and during the early stages of diabetes in the BB rat: effect of the level of glycemic control.
Pederson RA; Curtis SB; Chisholm CB; Gaba NR; Campos RV; Brown JC
Can J Physiol Pharmacol; 1991 Aug; 69(8):1230-6. PubMed ID: 1782606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
